Comment on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”

Comment on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”

Saved in:

Bibliographic Details
Main Authors:	Arnar B. Ingason, MD, PhD, Mitchell C. Norotsky, MD, FACS
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2024-06-01
Series:	Annals of Surgery Open
Online Access:	http://journals.lww.com/10.1097/AS9.0000000000000446
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to Letter to the Editor on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”
by: Naita M. Wirsik, MD, et al.
Published: (2024-09-01)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
by: Yuan Tian, et al.
Published: (2021-01-01)

Comment on “Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multi-Center, Real-World Risk-Matched Analysis”
by: Kilian A. Walter, et al.
Published: (2024-12-01)

Comment on “Surgical Margin of Resected Colorectal Liver Metastases: How Accurate Is Surgeon Prediction?”
by: Yoichiro Uchida, MD, PhD, et al.
Published: (2024-09-01)

Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma
by: Kai Tai Derek Yeung, PhD, FRCS, et al.
Published: (2024-09-01)

Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients
by: Yushi Nagaki, MD, PhD, et al.
Published: (2024-03-01)

Gastroesophageal junction adenocarcinoma. A case report
by: Marcos Félix Osorio Pagola, et al.
Published: (2010-12-01)

Comment on Published Article “Surgeon or Bot? The Risks of Using Artificial Intelligence in Surgical Journal Publications”
by: Hinpetch Daungsupawong, PhD, et al.
Published: (2023-12-01)

Response to Comment on: “Randomized Controlled Trial of Surgical Rib Fixation to Nonoperative Management in Severe Chest Wall Injury”
by: David E. Meyer, MD, MS, FACS, et al.
Published: (2024-03-01)

Management and Reconstruction of a Gastroesophageal Junction Adenocarcinoma Patient Three Years after Pancreaticoduodenectomy: A Surgical Puzzle
by: Dionysios Dellaportas, et al.
Published: (2016-01-01)

Response to: Comment on “Integrating Human Intuition into Prediction Algorithms for Improved Surgical Risk Stratification”
by: Margaret T. Berrigan, MD, MS, et al.
Published: (2024-12-01)

Patient Surgical Outcomes When Surgery Residents Are the Primary Surgeon by Intensity of Surgical Attending Supervision in Veterans Affairs Medical Centers
by: T. Michael Kashner, PhD, JD, MPH, et al.
Published: (2023-12-01)

Comment on: “Integrating Human Intuition into Prediction Algorithms for Improved Surgical Risk Stratification”
by: Elisabeth E. Smith, BMedSci, BMBS, et al.
Published: (2024-09-01)

The Accuracy of the NSQIP Universal Surgical Risk Calculator Compared to Operation-Specific Calculators
by: Mark E. Cohen, PhD, et al.
Published: (2023-12-01)

Response to: Comment on “Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial”
by: An T. Ngo-Huang, DO, et al.
Published: (2024-06-01)

Comment on Portal Hemodynamics in Liver Transplantation: Do not Shunt The Large-For-Flow!
by: Xavier Muller, MD, PhD, et al.
Published: (2024-06-01)

Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
by: Chengyang Yu, et al.
Published: (2025-01-01)

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy
by: Huanhuan Li, et al.
Published: (2025-02-01)

Kyoto International Consensus Report on Anatomy, Pathophysiology and Clinical Significance of the Gastroesophageal Junction
by: A. A. Sheptulin, et al.
Published: (2023-12-01)

Comment on: Age Matters. What Affects the Cumulative Lifespan of a Transplanted Liver?
by: Paolo De Simone, MD, PhD, et al.
Published: (2024-06-01)

Comment on “Celiac Axis Stenosis Is an Underestimated Risk Factor for Increased Morbidity After Pancreatoduodenectomy”
by: Nobuhiro Hasui, MD, PhD, et al.
Published: (2024-12-01)

Comment on “Addressing Vaccine Uptake in Trauma Patients”
by: Hinpetch Daungsupawong, PhD, et al.
Published: (2024-03-01)

Comment on “Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER)”: Multicenter Randomized Trial
by: Shuirong Lin, MD, et al.
Published: (2024-12-01)

The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs
by: Hongqiong Yang, et al.
Published: (2021-01-01)

Comment on “Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI Trial)”
by: Xi Yu, MD, et al.
Published: (2024-06-01)

Response to: Comment on “Dynamics of Serum CA 19-9 in Patients Undergoing Pancreatic Cancer Resection”
by: Vincent P. Groot, MD, PhD, et al.
Published: (2024-06-01)

Comment on “How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-Risk T1 Colorectal Cancer?”
by: Stanislas Chaussade, MD, PhD, et al.
Published: (2024-06-01)

Comment on “Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Kojiro Taura, MD, PhD, et al.
Published: (2023-12-01)

Risk Factors and Management of Portal Vein Thrombosis after Hepatectomy: A Single-Center Experience
by: Kazuki Wakizaka, MD, PhD, et al.
Published: (2024-12-01)

Response to Comment on: “Prognostic Relevance of Primary Tumor Sidedness in Early-Stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)”
by: Akira Ouchi, MD, PhD, et al.
Published: (2024-12-01)

Comment on “Refining Auxiliary Orthotopic Liver Transplantation (AOLT) Improves Outcomes in Adult Patients With Acute Liver Failure”
by: Fabien Robin, M.D., PhD, et al.
Published: (2024-03-01)

Response to: Comment on “Risk Models for Developing Pancreatic Fistula After Pancreatoduodenectomy: Validation in a Nationwide Prospective Cohort”
by: Thijs J. Schouten, MD, et al.
Published: (2024-06-01)

Comment on “Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial”
by: Enea M. Ghielmini, MD, et al.
Published: (2023-12-01)

Comment on: A Contemporary Analysis of Discharge Disposition Following Total Joint Arthroplasty
by: Francesco Pegreffi, MD, PhD, et al.
Published: (2025-04-01)

Comment on “Age Matters: What Affects the Cumulative Lifespan of a Transplanted Liver?”
by: Miho Akabane, MD, et al.
Published: (2024-09-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Comment on “Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma”
by: Xu Wang, MD, et al.
Published: (2024-06-01)

Response to: “Comment on: Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Yeshong Park, MD, et al.
Published: (2023-12-01)

Delayed surgical management of an Amplatzer device migration into the aortoiliac bifurcation
by: David Gadoin, MD, et al.
Published: (2025-02-01)

Effects of Minimally Invasive Versus Open Pancreatoduodenectomy on Short-Term Surgical Outcomes and Postoperative Nutritional and Immunological Statuses: A Single-Institution Propensity Score-Matched Study
by: Shinsei Yumoto, MD, et al.
Published: (2024-09-01)